Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Sullivan

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
Cancer|October 24, 2018
Reply to emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomesAlexander T Faje, Ryan J Sullivan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant MelanomaJustine V Cohen, Ryan J Sullivan
Cancer Journal (Sudbury, Mass.)|March 25, 2024
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?Matthew J Hadfield, Ryan J Sullivan
Expert Opinion on Investigational Drugs|August 7, 2010
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyondRyan J Sullivan, Michael B Atkins
Nature Reviews. Clinical Oncology|September 30, 2015
Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanomaRyan J Sullivan, Keith T Flaherty
Future Oncology (London, England)|August 5, 2017
Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeuticsMeghan J Mooradian, Ryan J Sullivan
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Emerging clinical issues in melanoma in the molecularly targeted eraRyan J Sullivan, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
Pembrolizumab for Treatment of Patients with Advanced or Unresectable MelanomaRyan J Sullivan, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
New strategies in melanoma: entering the era of combinatorial therapyRyan J Sullivan, Keith T Flaherty
The Journal of Organic Chemistry|March 24, 2020
Reaction Cycling for Kinetic Analysis in FlowRyan J Sullivan, Stephen G Newman
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
Cancer|October 24, 2018
Reply to emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomesAlexander T Faje, Ryan J Sullivan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant MelanomaJustine V Cohen, Ryan J Sullivan
Cancer Journal (Sudbury, Mass.)|March 25, 2024
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?Matthew J Hadfield, Ryan J Sullivan
Expert Opinion on Investigational Drugs|August 7, 2010
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyondRyan J Sullivan, Michael B Atkins
Nature Reviews. Clinical Oncology|September 30, 2015
Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanomaRyan J Sullivan, Keith T Flaherty
Future Oncology (London, England)|August 5, 2017
Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeuticsMeghan J Mooradian, Ryan J Sullivan
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Emerging clinical issues in melanoma in the molecularly targeted eraRyan J Sullivan, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
Pembrolizumab for Treatment of Patients with Advanced or Unresectable MelanomaRyan J Sullivan, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
New strategies in melanoma: entering the era of combinatorial therapyRyan J Sullivan, Keith T Flaherty
The Journal of Organic Chemistry|March 24, 2020
Reaction Cycling for Kinetic Analysis in FlowRyan J Sullivan, Stephen G Newman
Pageof 33